Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

3257 reported adverse events

Drugs of this class: LETERMOVIR

These side effects are most commonly reported by patients taking drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 718
1 DRUG INEFFECTIVE 295
2 CYTOMEGALOVIRUS INFECTION REACTIVATION 260
3 DEATH 196
4 ACUTE KIDNEY INJURY 178
5 CYTOMEGALOVIRUS INFECTION 173
6 DRUG INTERACTION 166
7 PRODUCT USE IN UNAPPROVED INDICATION 165
8 PANCYTOPENIA 153
9 DRUG RESISTANCE 99
See all common reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

Drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
1 ENCEPHALITIS CYTOMEGALOVIRUS 75 0.1712
2 RETINITIS VIRAL 16 0.1322
3 AUTOIMMUNE PANCYTOPENIA 10 0.1099
4 QUADRANTANOPIA 10 0.0763
5 EPSTEIN-BARR VIRAEMIA 69 0.0622
6 GINGIVITIS ULCERATIVE 13 0.0605
7 CYTOMEGALOVIRUS INFECTION REACTIVATION 260 0.0588
8 PARENTERAL NUTRITION 11 0.0476
9 ENGRAFT FAILURE 12 0.0418
See all enriched reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]